DuPont Leader Updates 2013 Agriculture Research Pipeline with Investors

Agriculture & Nutrition Segments Spur Growth, Product Development Across Food Value Chain

News provided by

Feb 26, 2013, 09:03 ET

NEW YORK, Feb. 26, 2013 /PRNewswire/ -- At the Goldman Sachs 17^th Annual Agribusiness Conference today, DuPont Executive Vice President James C. Borel highlighted 2013 growth drivers and advancements of its agriculture research pipeline to sustain innovation across its seed, crop protection and nutrition and health businesses. Recent portfolio changes continue to solidify DuPont's unique ability to address the global food security challenge by providing solutions across the food value chain.

"Ongoing global dynamics like increased urbanization in developing economies and consumer demand for protein-rich diets continue to strain today's agriculture and food system. Farmers, grocers and food manufacturers seek new innovations to produce and package safe, nutritious food," said Borel. "DuPont is uniquely positioned to leverage science to provide options and local solutions that help feed a growing global population."

DuPont's recent acquisition of Danisco and full ownership of Solae further strengthen the company's ability to bring new innovation and solutions to customers across the food value chain.

Borel discussed the 2013 agriculture research pipeline that features an integrated approach to product development including germplasm, native and biotech traits, with 12 product advancements including 4 program additions as a result of sustained R&D efforts.

Following the strong commercial launches of Optimum® AQUAmax™ hybrids, Optimum® AcreMax® insect protection and Optimum® AcreMax® Xtra products in 2012, this year's pipeline advancements underscore DuPont Pioneer's progress in bringing local solutions to growers' biggest challenges. Together with the solid growth of DuPont Crop Protection's DuPont™ Rynaxypyr®, and launches of DuPont™ Cyazypyr™, Dermacor® seed treatment and Penthiopyrad, DuPont's Agriculture pipeline is delivering today and poised for future growth.

"Our ability to unlock our strong seed germplasm potential using biotechnology, sustainable chemistry profiles and leading nutrition science demonstrates DuPont science at work for the global marketplace. Our unique routes-to-market, application development capabilities and local footprint ensures a close relationship with growers and food companies alike to bring tangible solutions from the ground up," Borel said.

Borel used the Brazil corn business as an example of successful product introductions combined with our advantaged route-to-market. Using advanced breeding and biotechnology, DuPont scientists have created unique products like Optimum® Intrasect®, with two modes of action for lepidopteran insect control, and early soybean varieties and corn hybrids uniquely designed to enable safrinha double-cropping systems. These high-yielding products with native and biotech protection, delivered through our system of local sales professionals helped DuPont Pioneer achieve a multi-point gain in corn market share in the Brazil summer season and position us for continued growth in the current safrinha season.

To view a full copy of today's presentation, visit the "Events & Presentations" page on the DuPont Investor Center.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. The company does not undertake to update any forward-looking statements as a result of future developments or new information. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont's filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

The DuPont Oval Logo, DuPont™, Optimum®, AQUAmax™, AcreMax®, Intrasect®, Rynaxypyr®, Cyazypyr™ and Dermacor® are trademarks or registered trademarks of DuPont or its affiliates.

SOURCE DuPont